Ottawa, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The global softgel capsules market size is expected to be worth over $17.27 billion by 2034, increasing from $10.85 billion in 2026, growing at a strong CAGR ...

Slightly bigger than a matchstick, lighter than a two-rupee coin and wireless.Patients may get this pacemaker by the middle of this year. "Besides being small, the implant has no wires and is ...

Pfizer, the world's biggest pharmaceuticals company, said Monday it has agreed to sell capsule-maker unit Capsugel to private-equity firm KKR for about $2.4 billion in cash. · Pfizer, the world's ...

(Reuters) - Swiss pharmaceutical supplier Lonza Group AG on Thursday announced a deal to buy Capsugel, a U.S. maker of capsules and other drug delivery systems, from KKR & Co LP for $5.5 billion in ...

The Swiss pharmaceutical services firm Lonza has agreed to acquire Capsugel, a specialist in oral drug delivery technologies, from the private equity firm KKR for $5.5 billion. The deal follows others ...

Dec 15 (Reuters) - Swiss pharmaceutical manufacturer Lonza Group AG said on Thursday it is buying Capsugel, a U.S. maker of capsule products and other drug delivery systems, for $5.5 billion in cash. ...

Pfizer said in a statement the proceeds from the sale would be used to buy back stock in addition to the previously announced repurchase program of about $5 billion planned for 2011. The New ...